These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 25093328)

  • 1. The periplasmic protein TolB as a potential drug target in Pseudomonas aeruginosa.
    Lo Sciuto A; Fernández-Piñar R; Bertuccini L; Iosi F; Superti F; Imperi F
    PLoS One; 2014; 9(8):e103784. PubMed ID: 25093328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo screening for novel essential cell-envelope proteins in Pseudomonas aeruginosa.
    Fernández-Piñar R; Lo Sciuto A; Rossi A; Ranucci S; Bragonzi A; Imperi F
    Sci Rep; 2015 Dec; 5():17593. PubMed ID: 26621210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined Treatment of 6-Gingerol Analog and Tobramycin for Inhibiting Pseudomonas aeruginosa Infections.
    Ham SY; Kim HS; Jo MJ; Lee JH; Byun Y; Ko GJ; Park HD
    Microbiol Spectr; 2021 Oct; 9(2):e0019221. PubMed ID: 34704784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudomonas aeruginosa LptE is crucial for LptD assembly, cell envelope integrity, antibiotic resistance and virulence.
    Lo Sciuto A; Martorana AM; Fernández-Piñar R; Mancone C; Polissi A; Imperi F
    Virulence; 2018; 9(1):1718-1733. PubMed ID: 30354941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid Polymyxin/Pseudomonas NP test for rapid detection of polymyxin susceptibility/resistance in Pseudomonas aeruginosa.
    Sadek M; Tinguely C; Poirel L; Nordmann P
    Eur J Clin Microbiol Infect Dis; 2020 Sep; 39(9):1657-1662. PubMed ID: 32318967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulatory effects of green coffee extract on las I and las R virulence-associated genes in Pseudomonas aeruginosa.
    Jamalifar H; Samadi N; Nowroozi J; Dezfulian M; Fazeli MR
    Daru; 2019 Jun; 27(1):35-42. PubMed ID: 31187452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiogram profile and virulence signatures of Pseudomonas aeruginosa isolates recovered from selected agrestic hospital effluents.
    Mapipa Q; Digban TO; Nnolim NE; Nwodo UU
    Sci Rep; 2021 Jun; 11(1):11800. PubMed ID: 34083705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time-Kill Evaluation of Antibiotic Combinations Containing Ceftazidime-Avibactam against Extensively Drug-Resistant Pseudomonas aeruginosa and Their Potential Role against Ceftazidime-Avibactam-Resistant Isolates.
    Montero MM; Domene Ochoa S; López-Causapé C; Luque S; Sorlí L; Campillo N; López Montesinos I; Padilla E; Prim N; Angulo-Brunet A; Grau S; Oliver A; Horcajada JP
    Microbiol Spectr; 2021 Sep; 9(1):e0058521. PubMed ID: 34319141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic selection in the treatment of acute invasive infections by Pseudomonas aeruginosa.
    Cardozo C; Rico V; Agüero D; Soriano A
    Rev Esp Quimioter; 2019 Sep; 32 Suppl 2(Suppl 2):32-34. PubMed ID: 31475807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coordination of las regulated virulence factors with Multidrug-Resistant and extensively drug-resistant in superbug strains of P. aeruginosa.
    Dehbashi S; Pourmand MR; Alikhani MY; Asl SS; Arabestani MR
    Mol Biol Rep; 2020 Jun; 47(6):4131-4143. PubMed ID: 32474845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review: Antibiotic discovery in the age of structural biology - a comprehensive overview with special reference to development of drugs for the treatment of Pseudomonas aeruginosa infection.
    Koehnke A; Friedrich RE
    In Vivo; 2015; 29(2):161-7. PubMed ID: 25792642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers Retain Activity against Multidrug-Resistant Pseudomonas aeruginosa
    Moustafa DA; Wu AW; Zamora D; Daly SM; Sturge CR; Pybus C; Geller BL; Goldberg JB; Greenberg DE
    mBio; 2021 Jan; 12(1):. PubMed ID: 33436433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of antibiotic resistance in Pseudomonas aeruginosa. Implications for empiric and definitive therapy.
    Ruiz-Garbajosa P; Cantón R
    Rev Esp Quimioter; 2017 Sep; 30 Suppl 1():8-12. PubMed ID: 28882007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial Activity of Ceftazidime-Avibactam, Ceftolozane-Tazobactam, Cefiderocol, and Novel Darobactin Analogs against Multidrug-Resistant Pseudomonas aeruginosa Isolates from Pediatric and Adolescent Cystic Fibrosis Patients.
    Marner M; Kolberg L; Horst J; Böhringer N; Hübner J; Kresna IDM; Liu Y; Mettal U; Wang L; Meyer-Bühn M; Mihajlovic S; Kappler M; Schäberle TF; von Both U
    Microbiol Spectr; 2023 Feb; 11(1):e0443722. PubMed ID: 36692293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pseudomonas aeruginosa: Pathogenicity and antimicrobial resistance in urinary tract infection].
    Paz-Zarza VM; Mangwani-Mordani S; Martínez-Maldonado A; Álvarez-Hernández D; Solano-Gálvez SG; Vázquez-López R
    Rev Chilena Infectol; 2019 Apr; 36(2):180-189. PubMed ID: 31344154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antibiotic therapy against Pseudomonas aeruginosa and other gram-negative bacteria in cystic fibrosis].
    Le Bourgeois M
    Arch Pediatr; 2003 Sep; 10 Suppl 2():352s-357s. PubMed ID: 14671934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolved Aztreonam Resistance Is Multifactorial and Can Produce Hypervirulence in
    Jorth P; McLean K; Ratjen A; Secor PR; Bautista GE; Ravishankar S; Rezayat A; Garudathri J; Harrison JJ; Harwood RA; Penewit K; Waalkes A; Singh PK; Salipante SJ
    mBio; 2017 Oct; 8(5):. PubMed ID: 29089424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment options for multidrug-resistant nonfermenters.
    Briceño DF; Quinn JP; Villegas MV
    Expert Rev Anti Infect Ther; 2010 Mar; 8(3):303-15. PubMed ID: 20192684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence of polymyxin B resistance influences pathogenicity in Pseudomonas aeruginosa mutators.
    Bulman ZP; Sutton MD; Ly NS; Bulitta JB; Holden PN; Nation RL; Li J; Tsuji BT
    Antimicrob Agents Chemother; 2015 Jul; 59(7):4343-6. PubMed ID: 25918151
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Janet-Maitre M; Job V; Bour M; Robert-Genthon M; Brugière S; Triponney P; Cobessi D; Couté Y; Jeannot K; Attrée I
    mBio; 2024 Mar; 15(3):e0221123. PubMed ID: 38345374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.